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Glycosylated Naphthalimides and Naphthalimide Tröger´s Bases 
as Fluorescent Aggregation Probes for Con A  
Elena Calatrava-Pérez,a Jason M. Delente,a Sankarasekaran Shanmugaraju,a Chris S. Hawes,b Clive 
D. Williams,c Thorfinnur Gunnlaugsson*a and Eoin M. Scanlan*a 
Herein we report the synthesis of fluorescent, glycosylated 4-amino-1,8-naphthalimide (Nap) 1, and the related 1,8-
naphthalimides Tröger´s bases (TBNap) 2 and 3, from 1,8-naphthalic anhydride precursors; the α-mannosides being 
introduced through the use of CuAAC mediated ‘click’ chemistry. We investigate the photophysical properties of these 
probes in buffered solution and demonstrate their ability to function as fluorescent probes for Concanavalin A (Con A) 
lectin. We show that both the Nap and TBNap structures self-assemble in solution. The formation of the resulting 
supramolecular structures is driven by head-to-tail pi−pi stacking and extended hydrogen bonding interactions of the Nap 
and the triazole moieties. These interactions give rise to spherical nano-structures (ca. 260 nm and 100 nm, for 1 and 3, 
respectively), which interact with the Con-A protein; the interaction being probed by using both luminescent and Scanning 
Electron Microscopy imaging as well as dynamic light scattering measurements. Finally, we show that these 
supramolecular assembles can be used as luminescent imaging agents, through confocal fluorescence imaging of HeLa 
cells of the per-acetylated version 2.   
Introduction  
The development of small-molecule targeted fluorescent 
probes and sensors remains an area of intensive research 
interest,1,2,3 particularly for use in live-cell analysis and imaging 
as high-resolution fluorescence imaging4,5 techniques have 
advanced significantly in recent times6. Applications of such 
probes include ion-sensing,7 subcellular imaging8 and protein 
tracking9 amongst other supramolecular applications10. 
However, significant challenges in the development of such 
probes arise because many molecular probes/sensors can be 
cytotoxic, give rise to immunogenic response, and are prone to 
enzymatic degradation.11 For real time imaging in cells, 
insufficient water solubility and lack of targeting ability for 
specific proteins and enzymes remains a major obstacle.12 We 
have recently demonstrated the real time monitoring of 
enzymatic activities in competitive media using enzyme 
targeting luminescent probes.11 We have also shown that 
enzymatic activation (e.g. hydrolysis), coupled with the use of 
fluorescent therapeutics, that have been structurally modified 
to be selectively recognised by a specific enzyme, can be 
employed in the generation of so called ‘pro-probes’. These 
are ‘probes’ or ‘bio-conjugates’, that only become active in 
vivo upon enzymatic triggered release of the therapeutic 
cargo; the release/delivery being probed by the emission from 
the cargo itself within cells.,11,14 Herein, we extend this 
strategy towards the use of proteins as the targeting carriers;15 
by developing the glycosylated 4-amino-1,8-aphthalimide 
(Nap) 1 and the a 9,18-methano-1,8-naphthalimide-
[b,f][1,5]diazocine ring fused, or Tröger´s base based 4-amino-
1,8-naphthalimide (TBNap) structure 2, Scheme 1, as 
fluorescent targeted Concanavalin A (Con A) lectin 
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   Lectins are proteins which specifically recognise and bind to 
carbohydrates.16 Lectins are involved in a wide range of 
biological processes; including regulation of cell adhesion, 
modulation of protein levels in blood, immune and 
inflammatory processes, glycoprotein synthesis and the 
promotion of cell-cell interactions.17 Lectins have important 
therapeutic applications in cancer treatment, and are 
biomarkers for disease and autophagy inducers.18,19 It is thus 
not surprising that lectin recognition is a topical area of 
research within supramolecular and medicinal chemistry.17  
    Con A is a lectin protein belonging to the legume-type family 
that preferably binds to α-linked mannosides, but it is also able 
to bind α-glucosides. With this in mind we designed probe 1, 
which consists of a single α-mannoside unit covalently linked 
to a Nap, Scheme 1. Above pH 7, Con A is presented as a 
tetramer; where each subunit is separated ca. 72 Å apart.20 
However, at mildly acidic pH, e.g. 4.5-5.5, Con A adopts a di-
meric structure. Each monomer contains two metal binding 
sites for Ca2+ and Mn2+ ions, which need to be occupied for the 
sugar binding to take place.21 In addition to the Nap derivative, 
we developed a divalent system by synthesising the bis α-
mannoside TBNap derivative 2, Scheme 1., in order to directly 
compare the interactions of the mono- vs. a divalent probe 
with ConA. In this article, we present the results from our 
investigation in the use of 1 and 2 as fluorescent aggregation 
probes for lectins in solution and compatibility in vitro with 
human cervical cancer cells. 
Results and discussion  
Design of Nap and TBNap based Lectin probes 
Using CuAAC chemistry, the Nap and TBNap probes 1 and 2, 
were synthesised as Con A targeted lectin probes; both being 
synthesised from their corresponding 1,8-naphthalic anhydride 
structures. Naps are well documented fluorophores, 
possessing internal charge transfer excited state (ICT), that 
have been extensively used in the development of florescent 
sensor for ions and molecules, and in medicinal chemistry.22,23 
In contrast to these, the TBNaps, are bi-naphthalimide 
systems, that we have recently developed the application of in 
significant detail; including their application as anticancer 
drugs, cellular imaging agents and in MOFs and coordination 
compounds and polymers, etc.24,25  
 
   Like Naps, TBNaps, also possess ICT excited state characters, 
though to lesser extent. Due to the methano-1,5-diazocine ring 
(N–CH2–N), the two naphthalimide components of the TBNaps 
units are almost orthogonal to each other, with dihedral angles 
ranging from 90 to 104°; thus making the TBNaps a highly 
desirable recognition motive for biomolecules. 24,25 With this in 
mind, both the Naps and the TBNaps were fully characterised 
using a range of photophysical techniques, their photophysical 
as well as their bioavailability properties were investigated.  
 
Synthesis and photophysical analysis of 1-3 
Mannosyl-naphthalimide conjugate 1 was prepared according 
to the reported literature procedures. 4-Nitro-1,8-napthalic 
anhydride and propargylamine, were first reacted together, 
followed by conjugation to the per-O-acylated mannoside 
derivative 6 using CuAAC mediated click chemistry under 
microwave assisted conditions. A reduction of this 
intermediate, to give the 4-amino analogue, using Pd/C and H2 
at 2 atm., followed by deprotection of the mannose unit, gave 
1 in good yield.11,26 The structure was fully characterised as 
shown in ESI.  
Fig. 1. Normalised absorption and emission spectra for 1 (black solid and black 
dotted) and 3 (red solid and red dotted). 
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Fig. 2 Changes in the fluorescence emission of a) 1 and b) 3 in DPBS at room 
temperature upon changing the concentrations of these two structures between 
1×10
-6
 to 1×10
-4 
M. Inset: The changes in the emission intensity at λ max as a 
function of increasing concentration of 1 and 3, respectively.   
 
a)
b)
    We have developed many examples TBNaps whereby imide 
end functionalised 3- or the 4-amino-1,8-naphthalimides are 
reacted with formaldehyde under acidic conditions. This 
normally results in the formation of the desired TBNaps. 
Unfortunately, this strategy did not work in this case, and the 
desired compound 3 was difficult to isolate in high purity or 
yield. Consequently, we moved towards synthesising 3 using 
an alternative route, based on the use of the TB anhydride 4, 
Scheme 1, which was recently developed in our laboratory, 
and structurally fully charatesised.27 The anhydride, can be 
formed in a signal step via nucleophilic substitution reaction 
from a single common ‘synthon’, a 5-dimethyl-isophthalate 
based TBNap (bis-[N-(5-dimethyl-isophthalate)]-9,18-
methano-1,8-naphthalimide [b,f][1,5]diazocine), upon 
treatment with aqueous KOH. The anhydride was reacted with 
propargylamine in refluxing ethanol to furnish the dialkyne 
compound 5 in 94% yield. Compound 5 was then reacted 
under CuAAC conditions in the presence of per-O-acylated 
mannoside derivative 6, displaying an alkylazide group at the 
anomeric position to furnish the protected product 2 in 65% 
yield. Treatment of 2 under Zemplén conditions furnished the 
desired product 3 in 98% yield. Both compounds 2 and 3 were 
characterised (c.f. Experimental and ESI) using conventional 
methods, including both NMR and HRMS. The 1H NMR of 2 
(400 MHz, DMSO-d6) indicated that some aggregation or self-
assembly formation occurred in solution, with several broad 
resonances assigned to the aromatic protons, while the 
protons assigned to the diazocine moiety appeared as well 
resolved set of signals between 5.5-5.0 ppm. The HRMS 
(MALDI) of 1-3 gave the accurate mass for [M+H]+; which in 
the case of 3, was found to be m/z = 1063.38054, for 
C51H55N10O16. 
 
Photophysical Characterisation of 1-3 
Amino-naphthalimides such as 1 have push-pull based 
intramolecular charge transfer (ICT) based photophysical 
properties. Their absorption and fluorescence emission spectra 
are therefore broad and occur within the UV-Vis and the 
visible regions, possessing moderately large Stokes shift, as 
shown in Fig. 1. Naps also normally possess reasonable 
lifetimes and quantum yields (ΦF).
 The photophysical 
characterisation of both 1 and 3 was carried in phosphate 
buffered saline (PBS) solution. Probe 1 displayed an absorption 
band centred ca. 430 nm (ε = 12,300 M-1cm-1) characteristic of 
the intramolecular charge transfer (ICT) process, and a 
fluorescence emission with its maximum at 530 nm upon 
excitation at λmax at 433 nm. The ΦF was also measured as 
under these conditions as 11% (see ESI for details). The 
fluorescence excitation spectrum mirrored that seen in the 
absorption spectrum (See ESI). In the case of 3, a broad 
absorption band centred at 380 nm (ε = 9,000 M-1cm-1), with a 
shoulder ca. 350 nm was observed. The emission spectra of 3 
showed a band centred at 510 nm. Therefore, both the 
absorption and emission spectra of the 1 are 50 nm blue-
shifted with respect to 3. This blue-shift is due to the 
substitution of the 4-amino group, reducing the ICT (the push-
pull) process. In a similar manner, the per-O-acetylated 
mannose 2, was also investigated and the UV-Vis absorption 
and emission spectra matched that observed for 3. 
 
Self-assembly formation in solution and solid-state analysis of 7 
As the Naps are known to take part in ‘head-to-tail’ 
aggregation through pi−pi interactions, aggregation studies 
were undertaken in solution, where both the absorption and 
the fluorescence emission were monitored for 1 and 3.nIt is 
also well known that sugars and short carbohydrates can self-
assemble into higher order structures. These studies were 
carried out in pH 7.2 DPBS (Dulbecco's phosphate-buffered 
saline), by varying the concentrations of these two structures 
between 1×10-6 to 1×10-4 M. While the absorption spectrum 
(See ESI) was not significantly affected, and the Beer-Lambert 
plot gave a linear slope, the florescence emission of both 
compounds was significantly affected at concentrations 
greater than 5×10-5 M in the case of 3. For both systems, the 
emission was quenched at elevated concentrations, Fig. 2.  
   In the case of 3, no significant changes were observed in the 
λ max, but for the TBNap 1, the aggregation seem to be 
occurring at slower rate, while being concomitantly causing 
blue shift in the λ max. The quenching is characteristic of 
naphthalimides pi−pi stacking interactions, in addition to 
hydrogen bonding interactions between the imide and the 4-
amino moieties of stacked Naps ‘dimers’.23c These interactions 
giving rise the formation of columns of such stacked 
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Fig. 3 a) Chemical structure of compound 7. (b) The X-ray crystal structure formed 
in H2O, and the extended pi−pi interactions, and (c) the two disordered orientations 
of the naphthalimide and alcohol fragments (minor conformer shown in green). 
 
structures, which are often stabilised by solvent interactions, 
such as hydrogen bonding to interstitial water protons. In the 
case of 1 and 3, we anticipated that these supramolecular 
interactions would be further aided by the mannoside 
moieties, which would be expected to take part in the 
formation of higher order self-assembly formations, through 
extended and multiple intermolecular hydrogen bonding 
interactions. 
    We have in the past characterised such ‘head-to-tail’ 
interactions both in solution as well as in the solid-state; these 
normally showing a clear hydrogen bonding interaction 
between the amino group of the Nap moiety.23c However, 
attempts to crystallise either 1 or 3 on all occasions did not 
result in the formations of crystals suitable for solid state 
crystallographic analysis. We were however, able to obtain 
crystals of the Nap structure 7, Fig. 3, which is structurally 
related to 1, with the exception that the mannoside moiety is 
missing. This ‘model’ compound was previously synthesised in 
our laboratory by subjecting a glycosylated Nap ‘pro-probe’ to 
the glycosidase enzymes β-galactosidase, which rapidly 
hydrolysed the glycosidic bond, concomitantly releasing 7 into 
cancer cells.11 7, and is a good model of 1, as it allows us gain 
inside into the various supramolecular interactions occurring 
at the Nap and the triazole moieties.  
   The structure of 7 is shown in Fig. 3a, as well as the packing 
in the solid state in Fig. 3b.  As can be seen in Fig. 3b, the Naps 
display pi−pi stacking interactions, being arranged with a near-
120° rotation between the major axes of each successive Nap. 
This orientation is different to what we have observed before, 
where a true head-to-tail orientation is typically observed. 
These interactions give rise to stacked columns; the chains are 
bent to shroud the exterior of the columns and engage in 
hydrogen bonding interactions with neighbouring groups.  
    There are three types of hydrogen bond donor in the 
compound: the amine and alcohol groups and the triazole C-H 
group. The alcohol and imide oxygen atoms and one triazole 
nitrogen atom act as hydrogen bond acceptors. The Nap 
molecules interact further with a molecule of water, shared 
between four Nap molecules, forming hydrogen-bonding 
interactions with the terminal alcohol. One could envisage that 
such interactions could be potentially greater for 1 and 3, 
given the number of additional hydrogen bonding 
acceptors/donors available. As the more directional 
interactions take place at the peripheries of the molecule, 
substantial crystallographic disorder is observed on the core 
atoms. This is related to the tendency of the central Naps to 
orient across two positions related by rotation (Fig. 3c), with a 
distribution 2:1 or 1:1 for the two unique residues. It is clear 
from these results that the Nap structures can partake in self-
assembly processes, that could result in the formation of 
higher-order materials, and that this could potentially affect 
their biological applications. As 1 and 3 were developed as 
fluorescent probes for Lectin protein, we set out to investigate 
both the affinity of this binding interaction, through the use of 
fluorescent titrations, as well as how this would affect the 
‘material’ nature of 1 and 3 using Scanning Electron 
Microscopy (SEM) imaging. 
 
Con A binding studies 
In order to investigate if the Nap compounds could function as 
molecular probes for lectin proteins, we evaluated the changes 
in their luminescent properties upon addition of Con A to 
solutions of 1 and 3. Based on our investigation above, we 
postulated that following addition of Con A, the carbohydrate-
lectin binding interactions would occur and potentially disrupt 
aggregates resulting in significant changes in the fluorescence. 
As a qualitative test, 0.1 equivalents of Con A were initially 
added to a 1 × 10-4 M solution of 1 and 3, respectively, Fig. 4a 
and b, in pH 7.2 DPBS solution, in the presence of 0.1 mM 
MnCl2 and 0.1 mM CaCl2 at 25 °C. In the case of 1, the 
fluorescence was enhanced significantly upon the addition of 
Con A, highlighting its ability to interact with Con A, and 
function as a lectin probe.  
   In contrast to this, the fluorescence intensity for 3 decreased 
at λem = 510 nm but a new shoulder appeared at 450 nm. This 
could possibly be due to the presence of the Tröger’s base 
moiety, which places the two Naps part almost orthogonal. 
We have observed similar effect upon binding Ru(II) 
polypyridyl based TBNap upon binding to DNA.25 Similarly, we 
analysed the binding of 2 to Con A. However, no changes were 
observed in the fluorescence emission, indicating that 
acetylated version was unable to bind to the protein in the 
same manner as 3 (See ESI). Having established that both 
compounds 1 and 3, interacted with Con A, a titration of 1 and 
3 (1 × 10-4 M) with Con A was undertaken (using final 
concentrations of Con A between 10-6 and 10-4 M). Here, 
significant changes were observed in the emission of 1, which 
was enhanced. The changes in the ICT band at 535 nm are 
shown in Fig. 4c as a function of emission enhancement (F-F0) 
where it is clear that the most significant changes occur at low 
concentrations of Con A; the emission showing a linear trend 
upon addition of Con A, until 9×10-5 M, after which a 
saturation point is reached. In a similar manner, the changes in 
the emission of 3 was monitored. While no significant changes 
were observed in the λmax at 510 nm, changes were observed 
at 450 nm shoulder, which also demonstrated a linear 
enhancement occurred within the same concentration window 
as that seen for 1, namely, between 2×10-6 and 8×10-5 M of 
Con A. The titrations also showed that below 1 µM Con A 
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Fig. 4 Changes in the fluorescence emission intensity of 1 (a and c) and 3 (b and d), 
respectively, upon addition of 0.1 Equiv. of Con A and varying concentrations of 
Con A. in pH 7.2 DPBS solution, in the presence of 0.1 mM MnCl2 and 0.1 mM CaCl2 
at 25°C. 
a) b) 
c) d) 
 
Fig. 5. Normalised fluorescence Intensity of 1 (blue) and 3 (magenta) in the 
presence of different biomolecules, in pH 7.2 DPBS solution, in the presence of 0.1 
mM MnCl2 and 0.1 mM CaCl2 at 25°C. 
 
 
concentration, no changes were observed, Fig. 4c and d. 
Unfortunately, we were unable to accurately determine the 
binding affinity for these interactions.  
 
Binding Selectivity 
Encouraged by the positive results obtained with 1, we set out 
to investigate the effect of the Con A binding under varying 
conditions, and the results are summarised in Fig. 5. As can be 
seen in Fig. 5, the addition of Con A (0.1 equivalents) led to a 
ca. 70% increase in the fluorescent intensity of 1. The addition 
of two-fold excess of α-D-mannose (compare to Con A) did not 
affect the emission properties. This could indicate that the 
probe was fully bound at this concentration. Similarly, no 
further quenching was observed for 3 upon addition of α-D-
mannose at this concentration. In a separate experiment, the 
probes were incubated with de-natured Con A (heated at 80 °C 
for 30 min), and no relevant changes in the fluorescent 
emission were observed, demonstrating that only a specific 
binding interaction between Con A and the two probes 
induces a change in the luminescence.  
   To further validate the binding interactions, the probes were 
treated with 0.1 equiv. of Bovine Serum Albumin (BSA). 
Albumin is a prevalent macromolecular transporter protein 
found in the blood stream due to its capacity to bind and carry 
small molecules. Significantly, no changes were observed in 
the luminescence of 1 and 3 in the presence of BSA, 
demonstrating that the fluorescence changes observed are 
exclusively due to the selective binding with Con A. Following 
this experiment, Con A (0.1 equiv) was added to this mixture 
to investigate if the presence of BSA would interfere with 
binding seen above. Gratifyingly, the fluorescence changes 
followed the same trend as the experiment conducted in the 
absence of BSA, highlighting that lectin-carbohydrate binding 
remains efficient in the presence of other macromolecules. 
This is an important finding in view of these compounds having 
application as molecular probes in vitro.  
     We repeated this experiment using another relevant lectin 
Peanut Agglutinin (PNA) which preferably binds to β-Gal-(1-3)-
β-GalNAc units, and identical, non-bonding, behaviour was 
observed for both 1 and 3. Therefore the changes in the 
luminescence are clearly only due to the selective binding 
between the α-mannosides probes and Con A. Finally, as a 
negative control, two structurally related Naps, that have 
previously developed in our laboratory,11 possessing a β-
galactoside (Gal-Nap) and β-Lactoside (Lac-Nap) moiety 
instead of the mannose site employed here, as well as 2, were 
treated with Con A (0.1 equiv) under identical conditions as 
described above. Importantly, only negligible changes were 
observed in the fluorescence intensity of all of these probes 
(See ESI) upon addition of Con A. We believe that this 
demonstrates that the aggregation of 1 and 3 is significantly 
affected upon binding to Con A. As we were unable to 
accurately determining the binding constants for the 
interaction of 1 and 3 for Con A, we set out to probe if the 
nanostructure (e.g. the morphology of self-assembly structure 
of 1 and 3) would be affected upon binding to Con A. This 
elucidation was carried out by using SEM imaging. 
 
Morphology studies 
The self-assembly or aggregation of 1 and 3 was observed 
above in solution. To investigate further the material nature of 
these assembles, pH 7.2 DPBS solution of 1 and 3 were drop 
casted onto silicon wafer, dried in air and imaged using SEM. 
The results are shown in Fig. 6 (see also ESI). From this 
imaging, it is clear that both 1 and 3 form particles; these being 
of ca. 260 nm and 100 nm average size, Fig. 6a and b, for 1 and 
3 respectively (it is also possible to see some salt formation, 
due to the buffer from which these were casted from). These 
images further support out findings above that both the Nap 
and the TBNaps form self-assembly structures in solutions. The 
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Fig. 6. SEM images of 1 before (a) and after addition of 0.1 Equiv. of Con A (c) and 3 before (b) and after addition of 0.1 Equiv. of Con A (d), showing significant morphological 
changes that demonstrate the binding with Con A, after drop-casting from buffered pH 7.2 solutions of these compounds. The formation of salts is also visible in these images.  
 
 
Fig. 7. Confocal images of HeLa cells treated with compound 1 (50 µM, first row), 
compound 3 (50 µM, second row) and compound 2 (50 µM, third row) after 24 h 
incubations. Compounds were excited by a 405 nm argon laser, emission 450-550 
nm, DRAQ5 was excited by a 633 nm red helium-neon laser, emission >650 nm. 
*Compound 3 was not incubated with DRAQ5 as it quenched its fluorescence 
emission. 
 
changes in the morphology of both of our probes when 
interacting with Con A, was next carried out. The SEM images 
of these are shown in Fig. 6c and d; the samples being formed 
in identical manner except in the presence of 0.2 equivalents 
of Con A, and 0.1 mM MnCl2 and 0.1 mM CaCl2, followed by 
drop casting and drying in air. It is clear form Fig. 6c and d, that 
the presence of the Con A. and the salts has significant effect 
on the morphology of both 1 and 3. While some indications of 
the presence of the nanospheres can be seen for 1, it is clear 
that significant aggregation has occurred in the present of the 
protein, and as above, in the presence of salts. However, SEM 
imaging of the protein itself (drop casted from buffered ionic 
solutions), demonstrated the formation of thick films which 
lack the morphology seen in Fig. 6c (See ESI).  
   Similarly, the morphology of the TBNap 3 in the present of 
Con A is significantly different to the self-assembly of 3 alone; 
the presence of larger aggregates is observed that seem to 
consist of spherical structures, some of which seem to indicate 
a ‘collapsed’ hallow-spheres. These results provided further 
evidence that these structures do interact with Con A resulting 
in changes in their morphological features. To probe if the 
DPBS buffer had an effect on the morphology of both probes, 
the samples were prepared in pure deionised water, and the 
resulting solution of 1 and 3 drop casted onto silicon wafer, 
dried in air followed by few hours under vacuum and imaged 
using SEM (See ESI). Gratifyingly, the two samples showed 
similar morphology to that seen for samples prepared in DPBS 
demonstrating that the buffer did not influence the 
morphology of both probes and that the changes observed 
previously are due to the presence of Con A. This observation 
was also supported by DLS measurement that were carried out 
on 3 in both the absence and presence of Con A in DPBS 
buffer. Here, the DLS showed that the average size of the 
aggregates in solution for the 3 alone was similar to that seen 
in the SEM, while these were almost ten times the size upon 
interacting with Con A (See ESI).   
 
Biological Evaluation 
Having demonstrated that 1 and 3 could interact with lectin 
proteins, and that no interaction was seen with proteins such 
as BSA (Fig. 5), we investigated the biological scope of 1 - 3 in 
vitro using human cervical cancer cells (HeLa). We have 
previously performed uptake studies of 1 across various cell 
lines where no uptake was observed, even after long 
incubation times (24 h) (Fig. 7, first row). However, 3 was 
shown to localize within the cytosol of the HeLa cells  (Fig. 7, 
second row) within 24 h; possibly due to the greater 
lipophilicity of 3 vs. 1. However, compound 3 was not shown 
to be toxic, with IC50 values >100 µM (evaluated via Alamar 
Blue assay). Longer incubation times (72 h), also resulted in 
IC50 that were greater than 100 µM, therefore it can be 
concluded that 3 could be used safely in vitro. To support this 
rationale, compound 2 was also evaluated in vitro, as the 
protected mannose units make it even more lipophilic and 
therefore more prone to cellular uptake. Incubation in HeLa 
cells (Fig. 7, third row) showed a greater uptake than either 1 
or 3. However, due to its high hydrophobicity it was observed 
to form aggregates in aqueous solution. Interestingly, short 
times of incubation (of ca. 1 h) showed larger aggregates that 
are more challenging for cellular uptake, and these aggregates 
interact with the cell membrane (see ESI). After longer times 
(24 h), the aggregates reduce in size and are increasingly 
accumulated within the cells. Confocal imaging analysis 
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through the use of Z-stacks images proved that the smaller 
aggregates were indeed located inside the cells whereas the 
larger ones only interact with the cell membrane (see ESI).  
Conclusions 
Two structurally related glyconaphthalimide probes were 
prepared and their photophysical and self-assembly properties 
investigated. Their ability to function as fluorogenic molecular 
probes for lectin binding was studied and it was demonstrated 
that carbohydrate-lectin interactions resulted in a disruption 
of aggregation that resulted in significant changes in 
fluorescence. Binding studies in the presence of non-lectin 
proteins demonstrated that changes in the luminescence arise 
from selective binding interactions between the α-mannosides 
probes and Con A and highlight the potential of these probes 
for in vitro and in vivo applications. The monovalent 1 probe 
was found to be superior to 3 for lectin detection although 3 
more readily underwent cellular uptake in HeLa cells. Detailed 
morphology studies further confirmed the disruption of 
aggregates upon carbohydrate-lectin binding interactions. This 
proof of principle opens novel avenues for molecular probe 
design using naphthalimide derivatives. We are currently 
investigating the use of TBNap structures as supramolecular 
synthons for the formation of self-assemble in solutions for 
applications in chemical biology. 
Experimental 
 
Materials and Methods 
Unless otherwise stated; all commercial chemicals were 
obtained from Sigma-Aldrich or Fluka and used without further 
purification. Deuterated solvents for NMR use were purchased 
from Apollo. Dry solvents were distilled under Argon and dried 
over 4 Å molecular sieves prior to use. Solvents for synthesis 
purposes were used at GPR grade. NMR spectra were recorded 
on Bruker DPX–400 Advance spectrometers, operating at 
400.13 MHz and 600.1 MHz for 1H NMR; 100.6 MHz and 150.9 
MHz for 13C-NMR. Shifts are referenced to the internal solvent 
signals.1 NMR data were processed using Mestrenova 
software. HRMS spectra were measured on a Micromass LCT 
electrospray TOF instrument with a WATERS 2690 autosampler 
and methanol/acetonitrile as carrier solvent. Melting points 
were determined using a Stuart Scientific Melting point was 
determined using an Electrochemical IA9000 digital melting 
point apparatus in an unsealed capillary tube and are 
incorrect. Infrared spectra were recorded on a Perkin Elmer 
Spectrum One FT-IR Spectrometer equipped with a Universal 
ATR sampling accessory. Carbohydrate positions are named 1 
to 6, starting the count in the anomeric position. 
 
UV/Vis Measurements 
UV-visible absorption spectra and optical density were 
recorded by means of a Varian CARY 50 spectrophotometer. 
Solutions were measured in 3 cm (10 mm x 10 mm) cuvettes. 
The wavelength range was 200-600 nm with a scan rate of 300 
nm min-1. The solvents employed were HPLC or 
spectrophotometric grade. 
 
Fluorescence Measurements 
Fluorescence measurements were made with a Varian Carey 
Eclipse Fluorimeter equipped with a 1.0 cm path length quartz 
cell. The solvents used were of HPLC grade. The concentrations 
of the compounds under investigation were the same as those 
used for the UV-visible absorption measurements. 
 
Cell Culture 
HeLa cells were grown in Dulbecco’s Modified Eagle Medium 
(Glutamax) supplemented with 10% fetal bovine serum, 1% 
penicillin/streptomycin and 0.2% of plasmocin at 37˚C in a 
humidified atmosphere of 5% CO2.  
 
Alamar Blue Viability Assay 
HeLa cells were seeded at a density of 2.5x104 cells/well in 96-
well plates and treated with the indicated compounds for 24 
or 72 h. Alamar blue (22 µl) was then added to each well and 
incubated at 37 °C in the dark for 4 h. Plates were then read on 
a fluorescence plate reader (SpectraMax Gemini, Molecular 
Devices) with excitement and emission wavelengths of 544 nm 
and 590 nm, respectively. Experiments were performed in 
triplicate on three independent days with activity expressed as 
percentage cell viability compared to vehicle treated controls. 
All data points (expressed as means ± S.E.M.) were analysed 
using GRAPHPAD Prism (Graphpad software Inc., San Diego, 
CA). 
 
Confocal Microscopy 
Cells were seeded at a density of 5x104 cells/dish in glass 
bottom wells and leave to grow for 24 h. Before treatment cell 
media was replaced by phenol-red free media and cells were 
incubated with compounds (50 µM) for 1 and 24 h, 
respectively. Cells were stained with DRAQ5 (red nuclear 
stain), followed by viewing using Leica SP8 STED confocal 
microscopy with a 40X oil immersion lens. Image analysis was 
performed using Leica Application Suite software. Compounds 
were excited by a 405 nm argon laser, emission 450-550 nm, 
DRAQ5 was excited by a 633 nm red helium-neon laser, 
emission >650 nm. Images are representative of three 
independent experiments.  
 
Scanning Electron Microscopy 
The morphology of the samples were studied using a Carl Zeiss 
Ultra SEM with an SE2 or in-lens detector in the Advanced 
Microscopy Laboratory, CRANN, Trinity College Dublin, with 
the samples deposited on silicon wafers with a thick silicon 
dioxide layer. Prior to imaging, all samples were coated with a 
conductive layer of Pd/Au using a Cressington 208Hr high-
resolution sputter coater. 
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X-ray Crystallography 
The diffraction data were collected on a Bruker APEX-II Duo 
dual-source instrument using microfocus Cu-Kα radiation (λ = 
1.5405 Å) using ω and φ scans. A single crystal was mounted 
on Mitegen micromounts in NVH immersion oil, and 
maintained at a temperature of 100 K using a Cobra 
cryostream. The diffraction data were reduced and processed 
using the Bruker APEX suite of programs.28 Multi-scan 
absorption corrections were applied using SADABS.29 The data 
were solved using the Intrinsic Phasing routine in SHELXT. 
Although the chiral space group P21212 gave the best statistics 
and most appropriate structure model, no chirality 
information is assumed and the structure was refined as a 
racemic twin with full-matrix least squares procedures using 
SHELXL-2015 within the OLEX-2 GUI.30-32.  All non-hydrogen 
atoms were refined with anisotropic displacement parameters. 
All hydrogen atoms were placed in calculated positions and 
refined with a riding model, with isotropic displacement 
parameters equal to either 1.2 or 1.5 times the isotropic 
equivalent of their carrier atoms. Due to the severe disorder in 
the naphthalimide fragments of both unique molecules, DFIX, 
SADI and RIGU restraints and EADP constraints were necessary 
to maintain reasonable chemical geometries and Uij tensors, 
particularly where atoms from both fragments were closely 
overlapping. Occupancies of the individual conformers were 
determined with free variable refinement and then fixed to 
sensible fractional values. Specific collection and refinement 
strategies are further outlined in the combined 
crystallographic information file (cif) under the 
_refine_special_details heading. CCDC 1866499. 
 
Crystal Data for compound 7 (C36H35N10O6.5, M =711.74 
g/mol): orthorhombic, space group P21212 (no. 18), a = 
17.0714(12) Å, b = 27.849(2) Å, c = 6.8249(3) Å, V = 
3244.7(4) Å3, Z = 4, T = 100.0 K, μ(CuKα) = 0.859 mm-1, Dcalc = 
1.457 g/cm3, 21933 reflections measured (6.072° ≤ 2Θ ≤ 
137.048°), 5941 unique (Rint = 0.0536, Rsigma = 0.0544) which 
were used in all calculations. The final R1 was 0.0754 (I > 2σ(I)) 
and wR2 was 0.2039 (all data). 
 
 
Synthetic procedures 
 
Bis-[N-(1-(3-(2’,3’,4’,6’-tetra-O-acetyl-α-D-
mannopyranosyloxy)propyl)-1H-1’’,2’’,3’’-triazol-4’’-yl)methyl)-
9,18-methano-1,8-naphthalimide-[b,f ][1,5]diazocine (2) 
Compound 5 (28 mg, 0.05 mmol, 1 equiv), compound 1 (45 
mg, 0.1 mmol, 2 equiv) and Cu(BF4)(MeCN)4 (10 mg, 0.03 
mmol, 0.3 equiv) were dissolved in DMF (5 mL) in a microwave 
vial. The reaction mixture was stirred for 2 h at 115 °C in a 
microwave reactor. The solvent was removed in vacuo and the 
crude product dissolved in a mixture of MeOH/CH2Cl2 (1:2) and 
filtered through a plug of Celite® to remove the copper 
catalyst. The filtrate was concentrated in vacuo and purified by 
SiO2 column chromatography. The product was obatined as an 
orange wax (40 mg, 66%). 1H (799.7 MHz, CDCl3): 8.69 (bs, 2H, 
H-Ar), 8.62 (d, J = 11.4 Hz, 2H, H-Ar), 8.13 (s, 2H, H-Ar), 8.03 (s, 
2H, H-Ar), 7.86 (s, 2H, H-Ar), 7.61 (s, 2H), 5.42 (bs, 3H), 5.27 – 
5.24 (m, 4H, CH2), 5.21 (bs, 1H), 5.14 (app t, 2H, N-CH2), 4.76 
(s, 2H, H-1), 4.66 – 4.64 (m, 2H), 4.61 – 4.56 (m, 2H), 4.43 – 
4.39 (m, 2H), 4.38 – 4.34 (m, 2H), 4.20 – 4.35 (m, 2H), 4.05 (d, J 
= 12.6 Hz, 2H), 3.96 – 3.92 (s, 2H), 3.71 – 3.67 (s, 2H), 3.40 – 
3.35 (s, 2H), 2.14, 2.06, 2.05, 1.99 (s, 24H, OCOCH3), (2xCH2 
buried under OCOCH3). 
13
C (201.1 MHz, CDCl3): 153.6, 133.5 
(C-Ar), 129.8 (C-Ar), 100.4 (C-1), 71.9, 71.6 (C-CH2), 71.3, 69.6, 
68.5 (C-CH2), 67.3, 67.2, 65.0, 59.7 (C-16), 59.6, 39.2, 37.8, 
34.1, 33.7, 33.6, 23.6, 23.5, 23.4, 23.3, 22.4 (7C, OCOCH3). νmax 
(ATR)/cm-1: 789, 1051 (C-N), 1229 (C-N), 1373, 1597 (ar. C-C), 
1659 (C=O), 1747, 2923. HRMS (m/z - MALDI): Found: 
1421.4504, ([M+Na]+. C67H70N10O24Na, Required: 1421.4462). 
 
Bis-[N-(1-(3-(α-D-mannopyranosyloxy)propyl)-1H-1’,2’,3’-
triazol-4’-yl)methyl)-9,18-methano-1,8-naphthalimide-[b,f 
][1,5]diazocine (3) 
Compound 2 (40 mg, 0.028 mmol, 1 equiv) was dissolved in 
MeOH/NaOMe (5 mL, 0.4 equiv). After stirring for 4 h at rt, 
DOWEX® 50WX8-200 ion exchange resin was added to the 
mixture until a neutral pH was measured. The reaction mixture 
was filtered and the filtrate concentrated in vacuo. Yielding the 
desired product as an orange powder (28 mg, 98%). M.p: 
120.5 – 122.0 °C (decomposition). 1H (400 MHz, d-TFA): 9.05 
(d, J = 8.0 Hz, 2H, H-Ar), 8.99 (d, J = 7.2 Hz, 2H, H-Ar), 8.84 (s, 
2H, H-Ar), 8.65 – 8.59 (m, 2H, H-Ar), 8.36 (s, 2H, H-Ar), 5.96 (s, 
2H, H-Ar), 5.93 – 5.87 (m, 4H, CH2, H-Ar), 5.83 (s, 2H, N-CH2), 
5.32 – 5.29 (m, 2H), 5.28 – 5.25 (m, 2H), 5.22 (s, 2H), 5.00 – 
4.94 (s, 6H), 4.55 – 4.39 (m, 2H), 4.55 – 4.29 (m, 2H), 4.19 – 
4.08 (m, 4H), 3.81 – 3.75 (m, 2H). νmax (ATR)/cm
-1: 980, 1100, 
1490 (ar. C-C), 1750 (C=O), 3410 (OH/NH2). HRMS (m/z - ESI): 
Found: 1063.38054, ([M+H]+. C51H55N10O16, Required: 
1063.3792). 
 
Bis-[N-(1-propargyl)]-9,18-methano-1,8-naphthalimide- [b,f 
][1,5]diazocine (5) 
Compound 4 (100 mg, 0.21 mmol, 1 equiv) was reacted with 
propargylamine (35 µL, 0.54 mmol, 2.5 equiv) in EtOH (10 mL) 
at 80 °C for 16 h. After this time, the reaction mixture was 
filtered through celite and washed with cold EtOH leaving an 
orange solid (108 mg, 94%). M.p: 292-294 °C (decomposition). 
1
H (400 MHz, CDCl3): 8.72 (d, J = 8.4 Hz, 2H, H-Ar), 8.65 (d, J = 
7.2 Hz, 2H, H-Ar), 8.14 (s, 2H, H-Ar), 7.88 (app t, 2H, H-Ar), 5.15 
(d, J = 16.9 Hz, 1H, N-CH2), 4.88 (s, 4H, H-2), 4.68 (s, 2H, N-CH2-
N), 4.59 (d, J = 16.9 Hz, 2H, N-CH2). 
13
C (100 MHz, CDCl3): 
163.2, 162.6, 150.0, 131.6, 131.1, 131.0, 127.9, 127.78, 127.4, 
126.9, 122.5, 117.8, 79.8, 73.4, 66.4, 56.5, 31.2, 29.4, 19.0. νmax 
(ATR)/cm-1: 1033, 1661 (C=O), 1340 (ar. C-C), 2935 (CCH). 
HRMS (m/z - MALDI): Found: 537.1578, ([M+Na]+. 
C33H54N10O16Na, Required: 537.15557). 
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